Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Larsson, D. Balgoma, I. Delin, T. Gülen, G. Nilsson, H. Hägglund, K. Daham, J. Lawson, G. FitzGerald, B. Dahlén, C. Wheelock, S. E. Dahlén (Stockholm, Sweden; Philadelphia, United States Of America). Monitoring PGD₂ production in airway disease. Eur Respir J 2011; 38: Suppl. 55, 3348

Member's Comments

No comment yet.

Related content which might interest you: Treatment of airway disease Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK Year: 2016 Monitoring of airway resistance (Raw) in exacerbation of asthma Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Monitoring of airway diseases in children Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 The amount of endogenous particles in exhaled air is correlated to peripheral airway obstruction Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation Source: Eur Respir Rev 2015; 24: 204-215 Year: 2015 The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels Source: International Congress 2016 – Airway biomarkers Year: 2016 Assessing & monitoring airway diseases using lung function Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Essential roles of q110 in IL13 in airway remodelling in bronchial asthma Source: Annual Congress 2009 - Airways remodelling Year: 2009 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children Source: Annual Congress 2013 –Preschool wheeze Year: 2013